Are your company’s pre-approval information exchange (PIE) strategy and tactics aligned with the market and FDA guidance?


 Do you know:

• What data payers receive about your new products in development currently?
• What data they receive from other companies?
• What additional data they are looking for?
• How other manufacturers are communicating PIE information?
• How to leverage FormularyDecisions for pre-approval communication?
• How to integrate a Pre-Approval Dossier into your proactive communications plan?
• How to get everyone at your company on the same page?

Register for AMCP and Xcenda’s PIE Corporate Training to get the answers to these questions and become your company’s go-to expert on PIE.

The training will include oncology products and rare diseases given the number of these products in the biopharmaceutical pipeline.


Learn more.


Tuesday, Nov. 17: 2–4:30pm ET
• Gain insights from the 2020 benchmarking surveys of how manufacturers and payers are using PIE.
• Interact with a payer panel discuss how PIE is helping payers and manufacturers plan for new product introductions.

Thursday, Nov. 19: 2–4:30pm ET
• Discuss tactics and tools used to deliver pre-approval information and track utilization data by payers,including:

  • AMCP Format 4.1
  • FormularyDecisions platform

• Leverage key information presented in case studies to enhance or launch your PIE strategy.



Lisa Cashman, PharmD
Vice President, Specialty Solutions
MedImpact & AMCP Format Executive Committee

Laurie Fazio
Head, Market Acces
s Solutions & Growth Strategies

Jay Jackson, PharmD, MPH
Vice President

Dana McCormick, RPh
Director of Pharmacy
Blue Cross Blue Shield of Texas


Charlie Dragovich
Senior Director, Market Access & Business Development - West



Registration Cost Select

Pre-Approval Information Exchange (PIE): Implementing pre-approval communication strategies: Corporate Training Registration